Contains a molecular complex and nutrients that contribute to the normal maintenance of the digestive system.
Colilen IBS is indicated for the treatment of irritable bowel syndrome, characterized by pain, bloating, distension and abdominal discomfort, which may or may not be associated with changes in stool appearance and bowel irregularity (constipation, diarrhea or alternating between the two). Through its protective mechanism, Colilen IBS gradually reduces intestinal disorders and, depending on the intensity of the disorder, it is recommended to extend the treatment from 2 to 6 weeks and repeat it when the first symptoms reappear. Colilen IBS capsules act thanks to its patented molecular complex (IT no. 102012902020829) ActiMucin, composed of Resins, Polysaccharides and Polyphenols. ActiMucin, through a mechanical-physical mechanism, interacts with the intestinal mucous surface forming a protective film that protects the mucosa from contact with irritating substances. The product is recommended from 8 years old and is contraindicated during pregnancy and breastfeeding.